High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study.
Li J, Han Q, Huang Y, Wei Y, Zi J, Zhao L, Cai Z, Lu X, Xiao R, Zhang Y, Yang X, Xu H, Sun N, Zhuang W, Wu Z, Xia Y, Xu Y, He B, Zhu W, Min F, Chen Y, Ding B, Shi P, Xie J, Tang H, Liu Z, Li B, Sun Y, Qiu H, Duan L, Dovat E, Song C, SzeKely L, Dovat S, Ge Z.
Li J, et al. Among authors: ge z.
Blood Cancer J. 2022 Oct 28;12(10):145. doi: 10.1038/s41408-022-00740-3.
Blood Cancer J. 2022.
PMID: 36307399
Free PMC article.
Clinical Trial.
No abstract available.